REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Internacional de Colombia S.A.S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Laboratorio Internacional de Colombia S.A.S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Labinco is a company that produces and sells pharmaceutical products, chemical and medical substances and botanical products for the private and institutional markets. It covers the whole territory in Colombia and has a significant market share in this segment. In July 2011 the Chilean company Andromaco acquired 70% of Labinco, extending its presence in the country, which until then maintained through its subsidiary ABL Pharma Colombia.

Headquarters
Cra 32 A No 10 99
Bogota D.C.; Bogota D.C; Postal Code: 0602

Contact Details: Purchase the Laboratorio Internacional de Colombia S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Internacional de Colombia S.A.S report to view the information.
Outstanding Shares:
Purchase the Laboratorio Internacional de Colombia S.A.S report to view the information.
Registered Capital:
Purchase the Laboratorio Internacional de Colombia S.A.S report to view the information.
Incorporation Date:
September 22, 1992
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Laboratorio Internacional de Colombia S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
11.96%
Total operating revenue
11.52%
Operating profit (EBIT)
-24.96%
EBITDA
-23.88%
Net Profit (Loss) for the Period
-24.17%
Total assets
30.21%
Total equity
13.3%
Operating Profit Margin (ROS)
-7.04%
Net Profit Margin
-4.97%
Return on Equity (ROE)
-5.8%
Debt to Equity Ratio
-0.45%
Quick Ratio
-0.62%
Cash Ratio
-0.55%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?